116 related articles for article (PubMed ID: 34411666)
1. Paeonol Ameliorates Abdominal Aortic Aneurysm Progression by the NF-κB Pathway.
Chen S; Luo K; Bian S; Chen J; Qiu R; Wu X; Li G
Ann Vasc Surg; 2021 Nov; 77():255-262. PubMed ID: 34411666
[TBL] [Abstract][Full Text] [Related]
2. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.
Iida Y; Xu B; Xuan H; Glover KJ; Tanaka H; Hu X; Fujimura N; Wang W; Schultz JR; Turner CR; Dalman RL
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):718-26. PubMed ID: 23288157
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
Wang W; Xu B; Xuan H; Ge Y; Wang Y; Wang L; Huang J; Fu W; Michie SA; Dalman RL
J Vasc Surg; 2018 Nov; 68(5):1538-1550.e2. PubMed ID: 29242064
[TBL] [Abstract][Full Text] [Related]
4. Zinc Prevents Abdominal Aortic Aneurysm Formation by Induction of A20-Mediated Suppression of NF-κB Pathway.
Yan YW; Fan J; Bai SL; Hou WJ; Li X; Tong H
PLoS One; 2016; 11(2):e0148536. PubMed ID: 26918963
[TBL] [Abstract][Full Text] [Related]
5. Apigenin Prevent Abdominal Aortic Aneurysms Formation by Inhibiting the NF-κB Signaling Pathway.
Li D; Ma J; Wang L; Xin S
J Cardiovasc Pharmacol; 2020 Mar; 75(3):229-239. PubMed ID: 31821190
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
[TBL] [Abstract][Full Text] [Related]
7. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
8. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
[TBL] [Abstract][Full Text] [Related]
9. Spermidine Suppresses Development of Experimental Abdominal Aortic Aneurysms.
Liu S; Huang T; Liu R; Cai H; Pan B; Liao M; Yang P; Wang L; Huang J; Ge Y; Xu B; Wang W
J Am Heart Assoc; 2020 Apr; 9(8):e014757. PubMed ID: 32308093
[TBL] [Abstract][Full Text] [Related]
10. Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.
Jiang B; Wang M; Li X; Ren P; Li G; Wang Y; Wang L; Li X; Yang D; Qin L; Xin S
Microvasc Res; 2022 Mar; 140():104280. PubMed ID: 34856183
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of miR-188-5p Suppresses Progression of Experimental Abdominal Aortic Aneurysms.
Huang T; Liu S; Liu R; Pan B; Wang W
J Cardiovasc Pharmacol; 2021 Jan; 77(1):107-114. PubMed ID: 33105327
[TBL] [Abstract][Full Text] [Related]
12. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.
Kaneko H; Anzai T; Takahashi T; Kohno T; Shimoda M; Sasaki A; Shimizu H; Nagai T; Maekawa Y; Yoshimura K; Aoki H; Yoshikawa T; Okada Y; Yozu R; Ogawa S; Fukuda K
Cardiovasc Res; 2011 Jul; 91(2):358-67. PubMed ID: 21436157
[TBL] [Abstract][Full Text] [Related]
13. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
[TBL] [Abstract][Full Text] [Related]
14. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
Ding Y; Li X; Zhou M; Cai L; Tang H; Xie T; Shi Z; Fu W
Vascul Pharmacol; 2021 Feb; 136():106818. PubMed ID: 33227452
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia limits experimental aortic aneurysm progression.
Miyama N; Dua MM; Yeung JJ; Schultz GM; Asagami T; Sho E; Sho M; Dalman RL
J Vasc Surg; 2010 Oct; 52(4):975-83. PubMed ID: 20678880
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
[TBL] [Abstract][Full Text] [Related]
17. RANKL-mediated osteoclastogenic differentiation of macrophages in the abdominal aorta of angiotensin II-infused apolipoprotein E knockout mice.
Tanaka T; Kelly M; Takei Y; Yamanouchi D
J Vasc Surg; 2018 Dec; 68(6S):48S-59S.e1. PubMed ID: 29685509
[TBL] [Abstract][Full Text] [Related]
18. Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation.
Saito T; Hasegawa Y; Ishigaki Y; Yamada T; Gao J; Imai J; Uno K; Kaneko K; Ogihara T; Shimosawa T; Asano T; Fujita T; Oka Y; Katagiri H
Cardiovasc Res; 2013 Jan; 97(1):106-14. PubMed ID: 23015640
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
Martorell S; Hueso L; Gonzalez-Navarro H; Collado A; Sanz MJ; Piqueras L
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1587-97. PubMed ID: 27283745
[TBL] [Abstract][Full Text] [Related]
20. Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
Kurobe H; Matsuoka Y; Hirata Y; Sugasawa N; Maxfield MW; Sata M; Kitagawa T
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1501-8. PubMed ID: 23535154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
